129658-simple-red-square-icon-social-media-logos-l

Aquarius Population Health wins a prestigious SBEI grant from Innovate UK

By David Rowlands, Aug 17 2017 08:09AM

Work has begun to develop a digital value proposition tool for a novel rapid sexually transmitted infection (STI) test


Aquarius Population Health, a leading independent health economics consultancy, has recently been awarded an 18-month Innovate UK grant in collaboration with Atlas Genetics Ltd and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London (total £2,000,000). The funding will be used to develop evidence for health services to support the introduction of a new rapid diagnostic test. In 30-minutes the test can diagnose multiple sexually transmitted infections including chlamydia and gonorrhoea – infections which could take up to a week to diagnose using the current laboratory testing systems.


Dr Mike Harvey and Dr Susie Huntington from Aquarius Population Health will be leading the work from Aquarius Population Health - mapping patient pathways within sexual health clinics and building a digital value proposition tool. Understanding the patient pathway facilitates thinking about new and better ways of delivering care and optimising resources for clinics. The digital value proposition tool will enable UK-based sexual health services to anticipate the potential benefits, costs and cost-effectiveness of adopting the new test. It will also quantify the impact on patients, sexual health services and on public health more broadly.


Dr Elisabeth Adams, Managing Director of Aquarius Population Health, comments:


“We are very excited to collaborate on this Innovate UK funded project. We’re convinced that our innovative digital value proposition tool will help sexual health clinics in their commissioning and adoption of this new technology.”


Dr John Clarkson, Chief Executive Officer of Atlas Genetics, comments:


“We are delighted to have been selected for this substantial follow-on contract. The work being done by this collaboration will enable us to better understand how best to integrate our io® system into UK sexual health clinical practice. Innovate UK’s commitment to introducing new, pioneering approaches to healthcare validates both our technology and our leading role in molecular diagnostics.”


Dr Tariq Sadiq, Director of The Applied Diagnostic Research & Evaluation Unit (ADREU), at St George’s University of London (SGUL), comments:


“This is a highly exciting and innovative approach to overcoming the substantial challenges to getting great technology adopted into the NHS by shedding light on potential routes through the complex landscape of factors and obstacles in our health systems.”


DR_Logo

Hot Topics                                

biosure tht-myhiv-skyscraper tile DR_Logo